{14 (cenobamate 12.5 MG Oral Tablet) } Pack

RxCUI: 2683673
RxNorm name: {14 (cenobamate 12.5 MG Oral Tablet) } Pack
Display name: {14 (cenobamate 12.5 MG Oral Tablet) } Pack
Full name: {14 (cenobamate 12.5 MG Oral Tablet) } Pack
Term type: GPCK
Status: DailyMed mapping
Updated: 2026-06-04 23:38:59

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Xcopri	CENOBAMATE	SK Life Science, Inc.	565c2126-57ae-4e29-b443-723bbe7e2072	2025-08-25	Warnings, Adverse reactions	Exact identifier rxcui: 2683673

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
565c2126-57ae-4e29-b443-723bbe7e2072	{14 (cenobamate 12.5 MG Oral Tablet) } Pack [GPCK] · cenobamate Titration Pack - 12.5 MG 14 Count [PSN] · cenobamate Titration Pack - 12.5 MG 14 Count [SY]	3	43	These highlights do not include all the information needed to use XCOPRI safely and effectively. See full prescribing information for XCOPRI. XCOPRI ® (cenobamate tablets), for oral use, CV Initial U.S. Approval: 2020	20250925